ArticleNeurology(R) neuroimmunology & neuroinflammation2019
Natalizumab treatment reduces microglial activation in the white matter of the MS brain.
Marcus Sucksdorff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this papercites it